What is CaptureRx?
Founded in 2000 and headquartered in San Antonio, Texas, CaptureRx operates as a specialized technology provider focused on the 340B healthcare ecosystem. The company provides critical infrastructure for managing inventory and financial workflows associated with 340B prescriptions processed through contract pharmacy networks. By automating complex eligibility verification and compliance reporting, CaptureRx serves as a vital intermediary for covered entities seeking to optimize their participation in federal drug discount programs. Their platform is engineered to mitigate audit risks while ensuring seamless financial reconciliation across diverse pharmacy environments.
How much funding has CaptureRx raised?
CaptureRx has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in CaptureRx
PPP
Public-Private Partnership
What's next for CaptureRx?
As CaptureRx transitions into its next phase of enterprise-level growth, the focus is expected to shift toward scaling its compliance-as-a-service architecture. The recent capital injection provides the necessary liquidity to enhance its proprietary eligibility engines and expand its footprint within the national pharmacy network. Strategic priorities likely include the integration of advanced data analytics to further streamline 340B program management and the strengthening of its regulatory reporting capabilities. By leveraging this investment, the company is well-positioned to address the increasing demand for transparency and efficiency in pharmaceutical supply chain management, ensuring that covered entities can maximize their program benefits while maintaining rigorous adherence to federal standards.
See full CaptureRx company page
